Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial)
2007

Glutamine and Selenium in Parenteral Nutrition for Critically Ill Patients

Sample size: 500 publication Evidence: moderate

Author Information

Author(s): Peter JD Andrews, Alison Avenell, David Noble, Marion K Campbell, Claire G Battison, Bernard L Croal, William G Simpson, John Norrie, Luke D Vale, Jonathon Cook, Robyn de Verteuil, Anne C Milne

Primary Institution: University of Edinburgh

Hypothesis

Does the inclusion of glutamine, additional selenium or the two in combination, in a standard preparation of parenteral nutrition improve the outcome for critically ill patients particularly in terms of infections and mortality?

Conclusion

The trial aims to determine if glutamine and selenium supplementation in parenteral nutrition can reduce infections and mortality in critically ill patients.

Supporting Evidence

  • Mortality rates in the Intensive Care Unit and subsequent hospital mortality rates in the UK remain high.
  • Systematic reviews suggest that supplementing parenteral nutrition in critical illness with glutamine or selenium may reduce infections and mortality.
  • Pilot data has shown that more than 50% of participants developed infections, typically resistant organisms.

Takeaway

This study is trying to find out if adding glutamine and selenium to the food given through a vein helps very sick patients get better and not get infections.

Methodology

A 2 × 2 factorial, pragmatic, multicentre, double-blind, randomised controlled trial with an enrolment target of 500 patients.

Potential Biases

Potential bias in participant selection and reporting of outcomes.

Limitations

The trial may face challenges in recruitment and follow-up due to high mortality rates in critically ill patients.

Participant Demographics

Patients aged 16 years or over, expected to be in critical care for at least 48 hours, requiring parenteral nutrition.

Statistical Information

Confidence Interval

95% CI 0.67 to 0.99

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1745-6215-8-25

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication